According to data presented in a late-breaking oral presentation at the American Academy of Ophthalmology 2024 Annual Meeting ...

2024年世界眼科大会（WOC2024）的“年龄相关性黄斑变性最新进展”分会场中，来自全球的眼科专家们深入探讨了黄斑变性的前沿研究与治疗策略。报告涵盖了人工智能（AI）在地图性萎缩（GA）进展预测中的应用、双特异性抗体和高剂量药物在湿性黄斑变性管理中 ...

A retrospective case series suggested that faricimab (Vabysmo) intravitreal injections may be associated with rare cases of ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline one-year results from ...

A new study published in the Journal of American Medical Association showed that rare instances of noninfectious intraocular ...

The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic ...

Researchers led by the University Hospital Zurich have identified cases of sterile intraocular inflammation, including severe retinal vasculitis, associated with faricimab injections used to treat eye ...

早期分子临床推进顺利，初现BIC 潜力。ASKG712：继罗氏Faricimab 之后全球第二家进入临床阶段的VEGF/ANG2 眼科药物。ASKG712 治疗新生血管性年龄相关性 ...

Roche (RHHBY) announced positive topline one-year results from the open-label, single-arm phase IV ELEVATUM study evaluating Vabysmo ...

A recent study, published in the journal Nature looked into the six-month impact of switching to faricimab instead of ...

BARCELONA, Spain — Early findings from a real-world study of the dual-action antibody faricimab have shown sustained improvement in visual acuity and key biomarkers of retinal anatomy ...